Modular chimeric cytokine receptors with leucine zippers enhance the antitumour activity of CAR T cells via JAK/STAT signalling
- 30 November 2023
- journal article
- research article
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 8 (4) , 380-396
Abstract
The limited availability of cytokines in solid tumours hinders maintenance of the antitumour activity of chimeric antigen receptor (CAR) T cells. Cytokine receptor signalling pathways in CAR T cells can be activated by transgenic expression or injection of cytokines in the tumour, or by engineering the activation of cognate cytokine receptors. However, these strategies are constrained by toxicity arising from the activation of bystander cells, by the suboptimal biodistribution of the cytokines and by downregulation of the cognate receptor. Here we show that replacement of the extracellular domains of heterodimeric cytokine receptors in T cells with two leucine zipper motifs provides optimal Janus kinase/signal transducer and activator of transcription signalling. Such chimeric cytokine receptors, which can be generated for common γ-chain receptors, interleukin-10 and -12 receptors, enabled T cells to survive cytokine starvation without induction of autonomous cell growth, and augmented the effector function of CAR T cells in vitro in the setting of chronic antigen exposure and in human tumour xenografts in mice. As a modular design, leucine zippers can be used to generate constitutively active cytokine receptors in effector immune cells.Keywords
Funding Information
- American Lebanese Syrian Associated Charities
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (F31CA250401-01A1)
- U.S. Department of Health & Human Services | National Institutes of Health (R01NS121249, R01NS122859)
This publication has 67 references indexed in Scilit:
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell–mediated rejection of systemic lymphoma in immunodeficient miceBlood, 2010
- Genetic Manipulation of Tumor-specific Cytotoxic T Lymphocytes to Restore Responsiveness to IL-7Molecular Therapy, 2009
- Inflammation Directs Memory Precursor and Short-Lived Effector CD8+ T Cell Fates via the Graded Expression of T-bet Transcription FactorImmunity, 2007
- A guided tour into subcellular colocalization analysis in light microscopyJournal of Microscopy, 2006
- Forced Dimerization of gp130 Leads to Constitutive STAT3 Activation, Cytokine-independent Growth, and Blockade of Differentiation of Embryonic Stem CellsMolecular Biology of the Cell, 2006
- An inducible caspase 9 safety switch for T-cell therapyBlood, 2005
- Control of Effector CD8 + T Cell Function by the Transcription Factor EomesoderminScience, 2003
- Designed heterodimerizing leucine zippers with a ranger of pIs and stabilities up to 10−15 MProtein Science, 2001
- Functional Replacement of Cytokine Receptor Extracellular Domains by Leucine ZippersJournal of Biological Chemistry, 1996